Header Logo

Connection

ANAIS MALPICA to Retrospective Studies

Back to Details
This is a "connection" page, showing publications ANAIS MALPICA has written about Retrospective Studies.
ANAIS MALPICA
Connection Strength
0.305
Retrospective Studies
  1. TP53 variant allele frequency correlates with the chemotherapy response score in ovarian/fallopian tube/peritoneal high-grade serous carcinoma. Hum Pathol. 2021 09; 115:76-83.
    View in: PubMed
    Score: 0.039
  2. A 3-Tier Chemotherapy Response Score for Ovarian/Fallopian Tube/Peritoneal High-grade Serous Carcinoma: Is it Clinically Relevant? Am J Surg Pathol. 2020 02; 44(2):206-213.
    View in: PubMed
    Score: 0.035
  3. Ovarian intestinal type mucinous borderline tumors: are we ready for a nomenclature change? Int J Gynecol Pathol. 2010 Mar; 29(2):108-12.
    View in: PubMed
    Score: 0.018
  4. Uterine smooth muscle tumor of uncertain malignant potential: a retrospective analysis. Gynecol Oncol. 2009 Jun; 113(3):324-6.
    View in: PubMed
    Score: 0.017
  5. Primary retroperitoneal mucinous tumors: a clinicopathologic study of 18 cases. Am J Surg Pathol. 2009 Apr; 33(4):526-33.
    View in: PubMed
    Score: 0.017
  6. Metastatic colorectal adenocarcinoma involving the ovary with elevated serum CA125: a potential diagnostic pitfall. Gynecol Oncol. 2007 May; 105(2):395-8.
    View in: PubMed
    Score: 0.014
  7. Serous carcinoma of the ovary and peritoneum with metastases to the breast and axillary lymph nodes: a potential pitfall. Am J Surg Pathol. 2004 Dec; 28(12):1646-51.
    View in: PubMed
    Score: 0.012
  8. Metastatic melanoma to the vagina: clinicopathologic and immunohistochemical study of three cases and literature review. Int J Gynecol Pathol. 2003 Apr; 22(2):136-40.
    View in: PubMed
    Score: 0.011
  9. Contemporary primary treatment of women with stage II-IV low-grade serous ovarian/peritoneal cancer (LGSOC): Determinants of relapse and disease-free survival. Gynecol Oncol. 2022 11; 167(2):139-145.
    View in: PubMed
    Score: 0.011
  10. Uterine Inflammatory Myofibroblastic Neoplasms With Aggressive Behavior, Including an Epithelioid Inflammatory Myofibroblastic Sarcoma: A Clinicopathologic Study of 9 Cases. Am J Surg Pathol. 2022 01 01; 46(1):105-117.
    View in: PubMed
    Score: 0.010
  11. Immunohistochemical Loss of DPC4 in Tumors With Mucinous Differentiation Arising in or Involving the Gynecologic Tract. Int J Gynecol Pathol. 2021 Nov 01; 40(6):523-532.
    View in: PubMed
    Score: 0.010
  12. High-grade Neuroendocrine Carcinomas of the Vulva: A Clinicopathologic Study of 16 Cases. Am J Surg Pathol. 2021 03 01; 45(3):304-316.
    View in: PubMed
    Score: 0.009
  13. Ovarian mucinous neoplasms, intestinal type, in premenopausal patients, develop in abnormal ovaries. Hum Pathol. 2021 02; 108:32-41.
    View in: PubMed
    Score: 0.009
  14. Effects of Gastrointestinal-Type Chemotherapy in Women With Ovarian Mucinous Carcinoma. Obstet Gynecol. 2019 12; 134(6):1253-1259.
    View in: PubMed
    Score: 0.009
  15. Tumor Thickness and Mitotic Rate Robustly Predict Melanoma-Specific Survival in Patients with Primary Vulvar Melanoma: A Retrospective Review of 100 Cases. Clin Cancer Res. 2017 04 15; 23(8):2093-2104.
    View in: PubMed
    Score: 0.007
  16. Soft tissue sarcoma of the head and neck in children and adolescents. Cancer. 1996 Jan 01; 77(1):193-200.
    View in: PubMed
    Score: 0.007
  17. The role of secondary cytoreduction in low-grade serous ovarian cancer or peritoneal cancer. Gynecol Oncol. 2015 Jan; 136(1):25-9.
    View in: PubMed
    Score: 0.006
  18. Peritoneal washing cytologic analysis of ovarian serous tumors of low malignant potential to detect peritoneal implants and predict clinical outcome. Cancer Cytopathol. 2012 Aug 25; 120(4):238-44.
    View in: PubMed
    Score: 0.005
  19. Hormonal therapy for recurrent low-grade serous carcinoma of the ovary or peritoneum. Gynecol Oncol. 2012 Jun; 125(3):661-6.
    View in: PubMed
    Score: 0.005
  20. The impact of epithelial biomarkers, local immune response and human papillomavirus genotype in the regression of cervical intraepithelial neoplasia grades 2-3. J Clin Pathol. 2011 Apr; 64(4):303-7.
    View in: PubMed
    Score: 0.005
  21. Low-grade serous primary peritoneal carcinoma. Gynecol Oncol. 2011 Jun 01; 121(3):482-6.
    View in: PubMed
    Score: 0.005
  22. Local immune response in the microenvironment of CIN2-3 with and without spontaneous regression. Mod Pathol. 2010 Sep; 23(9):1231-40.
    View in: PubMed
    Score: 0.004
  23. Endometrial endometrioid adenocarcinoma of the uterine corpus involving the cervix: some cases probably represent independent primaries. Int J Gynecol Pathol. 2010 Mar; 29(2):146-56.
    View in: PubMed
    Score: 0.004
  24. Polypoid or non-polypoid? A novel dichotomous approach to uterine carcinosarcoma. Gynecol Oncol. 2009 Oct; 115(1):32-36.
    View in: PubMed
    Score: 0.004
  25. Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum. Gynecol Oncol. 2008 Mar; 108(3):510-4.
    View in: PubMed
    Score: 0.004
  26. Immunohistochemical overexpression of p16 and p53 in uterine serous carcinoma and ovarian high-grade serous carcinoma. Int J Gynecol Pathol. 2007 Jul; 26(3):328-33.
    View in: PubMed
    Score: 0.004
  27. Characteristics of recurrence in patients who underwent lymphatic mapping for vulvar cancer. Gynecol Oncol. 2004 Jan; 92(1):205-10.
    View in: PubMed
    Score: 0.003
  28. Groin recurrence in patients with vulvar cancer with negative nodes on superficial inguinal lymphadenectomy. Gynecol Oncol. 2003 Sep; 90(3):625-8.
    View in: PubMed
    Score: 0.003
  29. Ovarian steroid cell tumors: an immunohistochemical study including a comparison of calretinin with inhibin. Int J Gynecol Pathol. 2003 Apr; 22(2):162-7.
    View in: PubMed
    Score: 0.003
  30. Use of nuclear morphometry characteristics to distinguish between normal and abnormal cervical glandular histologies. Anal Cell Pathol. 2003; 25(4):193-200.
    View in: PubMed
    Score: 0.003
  31. Cisplatin and irinotecan (CPT-11) for peritoneal mesothelioma. Cancer Invest. 2003; 21(5):682-9.
    View in: PubMed
    Score: 0.003
  32. The association of benign and malignant ovarian adenofibromas with breast cancer and thyroid disorders. Int J Surg Pathol. 2002 Jan; 10(1):33-9.
    View in: PubMed
    Score: 0.003
  33. Epidermal growth factor receptor expression in cervical intraepithelial neoplasia and its modulation during an alpha-difluoromethylornithine chemoprevention trial. Clin Cancer Res. 1998 Jun; 4(6):1383-91.
    View in: PubMed
    Score: 0.002
  34. C-met proto-oncogene expression in benign and malignant human renal tissues. J Urol. 1997 Sep; 158(3 Pt 1):724-8.
    View in: PubMed
    Score: 0.002
  35. Development of a multivariate statistical algorithm to analyze human cervical tissue fluorescence spectra acquired in vivo. Lasers Surg Med. 1996; 19(1):46-62.
    View in: PubMed
    Score: 0.002
  36. Spectroscopic diagnosis of cervical intraepithelial neoplasia (CIN) in vivo using laser-induced fluorescence spectra at multiple excitation wavelengths. Lasers Surg Med. 1996; 19(1):63-74.
    View in: PubMed
    Score: 0.002
  37. Laryngeal involvement in epidermolysis bullosa. Ann Otol Rhinol Laryngol. 1994 Jul; 103(7):542-6.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.